KALA BIO, INC. Investing Cash Flow
KALA BIO, INC. (KALA) reported Investing Cash Flow of -$7.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-19
- KALA BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
- KALA BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$7.00M.
- KALA BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
- KALA BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $1.00K.
- KALA BIO, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$15.00K.
- KALA BIO, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$208.00K.
- KALA BIO, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$429.00K, a 100.68% decline from fiscal 2022.
- KALA BIO, INC. net cash provided by (used in) investing activities for fiscal 2022 was $62.72M, a 11.42% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$7.00M 10-Q · filed 2026-08-19 | -$7.00M derived: sum of 3 quarters · filed 2026-08-19 | -$7.00M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2026-03-31 | -$7.00M 10-Q · filed 2026-05-15 | -$7.00M derived: sum of 2 quarters · filed 2026-05-15 | -$7.00M derived: sum of 3 quarters · filed 2026-05-15 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.00K derived: sum of 2 quarters · filed 2026-04-15 | -$15.00K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$15.00K 10-Q · filed 2025-11-19 | |||||
| 2025-06-30 | -$16.00K 10-Q · filed 2026-08-19 | ||||||
| 2024-12-31 | -$69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$159.00K derived: sum of 2 quarters · filed 2026-04-15 | -$195.00K derived: sum of 3 quarters · filed 2026-04-15 | -$208.00K 10-K · filed 2026-04-15 | |||
| 2024-09-30 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$126.00K derived: sum of 2 quarters · filed 2025-11-19 | -$139.00K 10-Q · filed 2025-11-19 | -$146.00K derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$49.00K 10-Q · filed 2025-08-08 | -$56.00K derived: sum of 3 quarters · filed 2025-08-08 | $9.66M derived: sum of 4 quarters · filed 2025-08-08 | |||
| 2024-03-31 | -$13.00K 10-Q · filed 2025-05-14 | -$20.00K derived: sum of 2 quarters · filed 2025-05-14 | $9.70M derived: sum of 3 quarters · filed 2025-05-14 | -$334.00K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $9.71M derived: sum of 2 quarters · filed 2025-03-31 | -$321.00K derived: sum of 3 quarters · filed 2025-03-31 | -$429.00K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $9.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$314.00K derived: sum of 2 quarters · filed 2024-11-12 | -$422.00K 10-Q · filed 2024-11-12 | -$371.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$10.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$10.14M 10-Q · filed 2024-08-06 | -$10.09M derived: sum of 3 quarters · filed 2024-08-06 | $54.82M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | -$108.00K 10-Q · filed 2024-05-14 | -$57.00K derived: sum of 2 quarters · filed 2024-05-14 | $64.85M derived: sum of 3 quarters · filed 2024-05-14 | $67.68M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $64.96M derived: sum of 2 quarters · filed 2024-03-29 | $67.79M derived: sum of 3 quarters · filed 2024-03-29 | $62.72M 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $64.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $67.74M derived: sum of 2 quarters · filed 2023-11-13 | $62.67M 10-Q · filed 2023-11-13 | $58.04M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$2.25M 10-Q · filed 2023-08-04 | -$6.87M derived: sum of 3 quarters · filed 2023-08-04 | -$2.15M derived: sum of 4 quarters · filed 2023-08-04 | |||
| 2022-03-31 | -$5.07M 10-Q · filed 2023-05-09 | -$9.70M derived: sum of 2 quarters · filed 2023-05-09 | -$4.97M derived: sum of 3 quarters · filed 2023-05-09 | $17.70M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $98.00K derived: sum of 2 quarters · filed 2023-03-03 | $22.77M derived: sum of 3 quarters · filed 2023-03-03 | $70.80M 10-K · filed 2023-03-03 | |||
| 2021-09-30 | $4.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $27.39M derived: sum of 2 quarters · filed 2022-11-08 | $75.43M 10-Q · filed 2022-11-08 | $112.27M derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | $22.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $70.70M 10-Q · filed 2022-08-11 | $107.55M derived: sum of 3 quarters · filed 2022-08-11 | $49.95M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $48.03M 10-Q · filed 2022-05-16 | $84.87M derived: sum of 2 quarters · filed 2022-05-16 | $27.27M derived: sum of 3 quarters · filed 2022-05-16 | -$29.89M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $36.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$20.76M derived: sum of 2 quarters · filed 2022-03-29 | -$77.92M derived: sum of 3 quarters · filed 2022-03-29 | -$78.21M 10-K · filed 2022-03-29 | |||
| 2020-09-30 | -$57.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$114.76M derived: sum of 2 quarters · filed 2021-11-15 | -$115.05M 10-Q · filed 2021-11-15 | -$115.24M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$57.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$57.45M 10-Q · filed 2021-08-05 | -$57.64M derived: sum of 3 quarters · filed 2021-08-05 | -$57.84M derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | -$292.00K 10-Q · filed 2021-05-05 | -$480.00K derived: sum of 2 quarters · filed 2021-05-05 | -$684.00K derived: sum of 3 quarters · filed 2021-05-05 | -$1.18M derived: sum of 4 quarters · filed 2021-05-05 | |||
| 2019-12-31 | -$188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$392.00K derived: sum of 2 quarters · filed 2021-02-25 | -$891.00K derived: sum of 3 quarters · filed 2021-02-25 | -$1.33M 10-K · filed 2021-02-25 | |||
| 2019-09-30 | -$204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$703.00K derived: sum of 2 quarters · filed 2020-11-05 | -$1.15M 10-Q · filed 2020-11-05 | -$2.06M derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-06-30 | -$499.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$943.00K 10-Q · filed 2020-08-06 | -$1.85M derived: sum of 3 quarters · filed 2020-08-06 | -$1.98M derived: sum of 4 quarters · filed 2020-08-06 | |||
| 2019-03-31 | -$444.00K 10-Q · filed 2020-05-07 | -$1.35M derived: sum of 2 quarters · filed 2020-05-07 | -$1.48M derived: sum of 3 quarters · filed 2020-05-07 | -$1.65M derived: sum of 4 quarters · filed 2020-05-07 | |||
| 2018-12-31 | -$910.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | -$1.04M derived: sum of 2 quarters · filed 2020-02-12 | -$1.21M derived: sum of 3 quarters · filed 2020-02-12 | -$1.58M 10-K · filed 2020-02-12 | |||
| 2018-09-30 | -$127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$295.00K derived: sum of 2 quarters · filed 2019-11-07 | -$668.00K 10-Q · filed 2019-11-07 | -$950.00K derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | -$168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$541.00K 10-Q · filed 2019-08-06 | -$545.00K 10-Q · filed 2018-08-09 | -$823.00K derived: sum of 3 quarters · filed 2019-08-06 | -$912.00K derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2018-03-31 | -$373.00K 10-Q · filed 2019-05-09 | -$377.00K 10-Q · filed 2018-05-10 | -$655.00K derived: sum of 2 quarters · filed 2019-05-09 | -$744.00K derived: sum of 3 quarters · filed 2019-05-09 | -$781.00K derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | -$282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$371.00K derived: sum of 2 quarters · filed 2019-03-12 | -$408.00K derived: sum of 3 quarters · filed 2019-03-12 | -$480.00K 10-K · filed 2019-03-12 | |||
| 2017-09-30 | -$89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$126.00K derived: sum of 2 quarters · filed 2018-11-08 | -$198.00K 10-Q · filed 2018-11-08 | -$222.00K 10-Q · filed 2017-11-07 | -$256.00K derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$109.00K 10-Q · filed 2018-08-09 | -$134.00K 10-Q · filed 2017-08-31 | -$167.00K derived: sum of 3 quarters · filed 2018-08-09 | -$216.00K derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | -$72.00K 10-Q · filed 2018-05-10 | -$130.00K derived: sum of 2 quarters · filed 2018-05-10 | -$179.00K derived: sum of 3 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$107.00K derived: sum of 2 quarters · filed 2018-04-02 | -$153.00K 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | -$49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$95.00K 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | -$46.00K 10-Q · filed 2017-08-31 | ||||||
| 2015-12-31 | -$252.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |